A Cross-Sectional Study on the Drug Utilization of Sacubitril-Valsartan (Sacu V) in Patients with Heart Failure with Reduced Ejection Fraction Across Various Clinics in India
Cardiology Research and Cardiovascular Medicine · 06.03.2026 · 11 (1)
DOI: 10.29011/2575-7083.100296 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Cardiology Research and Cardiovascular Medicine, online erschienen am 06.03.2026.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). A Cross-Sectional Study on the Drug Utilization of Sacubitril-Valsartan (Sacu V) in Patients with Heart Failure with Reduced Ejection Fraction Across Various Clinics in India. Cardiology Research and Cardiovascular Medicine, 11(1). https://doi.org/10.29011/2575-7083.100296
Vancouver
A Cross-Sectional Study on the Drug Utilization of Sacubitril-Valsartan (Sacu V) in Patients with Heart Failure with Reduced Ejection Fraction Across Various Clinics in India. Cardiology Research and Cardiovascular Medicine. 2026;11(1). doi:10.29011/2575-7083.100296
BibTeX
@article{euvimed2026,
title = {A Cross-Sectional Study on the Drug Utilization of Sacubitril-Valsartan (Sacu V) in Patients with Heart Failure with Reduced Ejection Fraction Across Various Clinics in India},
journal = {Cardiology Research and Cardiovascular Medicine},
year = {2026},
volume = {11},
number = {1},
doi = {10.29011/2575-7083.100296}
}
EUVIMED